Drutz David 4
4 · Altimmune, Inc. · Filed Jun 16, 2022
Insider Transaction Report
Form 4
Drutz David
Director
Transactions
- Purchase
Common Stock, par value $0.0001
2022-06-15$8.00/sh+1,000$8,000→ 20,012 total
Holdings
- 333(indirect: See Footnote)
Common Stock, par value $0.0001
Footnotes (1)
- [F1]Represents Common Stock held by Pacific Biopharma Associates, LLC, of which the reporting person is the President.